Prostate Cancer - Results from #22520

Diffusion-weighted imaging for prostate cancer localization: Comparison of apparent diffusion coefficient values in cancerous, non-cancerous tissues and Gleason score of the radical prostatectomy specimens - Abstract August 13, 2013

Analysis of high-dose rate brachytherapy dose distribution resemblance in CyberKnife hypofractionated treatment plans of localized prostate cancer - Abstract August 12, 2013

Diffusion-weighted MRI of the prostate at 3.0T: Comparison of endorectal coil (ERC) MRI and phased-array coil (PAC) MRI-The impact of SNR on ADC measurement - Abstract August 12, 2013

Last resort surgical management of postradiation urinary cystitis after external beam radiation for prostate cancer: A monocentric analysis - Abstract August 12, 2013

Imaging of prostate carcinoma - Abstract August 12, 2013

Focal cryotherapy in the treatment of localized prostate cancer - Abstract August 12, 2013

Serum androgens as prognostic biomarkers in castration-resistant prostate cancer: Results from an analysis of a randomized phase III trial - Abstract August 12, 2013

Yonsei criteria: A new protocol for active surveillance in the era of robotic and local ablative surgeries - Abstract August 12, 2013

Effect of metformin on prostate cancer outcomes after radical prostatectomy - Abstract August 12, 2013

Biological dose escalation and hypofractionation: What is there to be gained and how will it best be done? - Abstract August 12, 2013

Molecular classification of prostate cancer progression: Foundation for marker-driven treatment of prostate cancer - Abstract August 12, 2013

Follow-up for clinically localized renal neoplasms: AUA Guideline - Abstract August 9, 2013

Skeletal-related events among breast and prostate cancer patients: Towards new treatment initiation in Malaysia's hospital setting - Abstract August 9, 2013

Molecular diagnosis of prostate cancer: Are we up to age? - Abstract August 9, 2013

The dilemma of a rising prostate-specific antigen level after local therapy: What are our options? - Abstract August 9, 2013

Monitoring the clinical outcomes in advanced prostate cancer: What imaging modalities and other markers are reliable? - Abstract August 9, 2013

Sarcopenia and change in body composition following maximal androgen suppression with abiraterone in men with castration-resistant prostate cancer - Abstract August 9, 2013

Laparoscopic versus robot-assisted bilateral nerve-sparing radical prostatectomy: Comparison of pentafecta rates for a single surgeon - Abstract August 9, 2013

Prostate cancer in Luxembourg from 1982 to 2006. Incidence and mortality. Survival of a hospital cohort - Abstract August 9, 2013

Clinical implications of current developments in genitourinary pathology - Abstract August 9, 2013

Page 1127 of 1435